Coronavirus Disease-2019 (COVID-19) and Cardiovascular Complications

J Cardiothorac Vasc Anesth. 2021 Jun;35(6):1860-1865. doi: 10.1053/j.jvca.2020.04.041. Epub 2020 Apr 30.

Abstract

The coronavirus disease-2019 (COVID-19) has become a global pandemic. It has spread to more than 100 countries, and more than 1 million cases have been confirmed. Although coronavirus causes severe respiratory infections in humans, accumulating data have demonstrated cardiac complications and poor outcome in patients with COVID-19. A large percent of patients have underlying cardiovascular disease, and they are at a high risk of developing cardiac complications. The basics of the virus, the clinical manifestations, and the possible mechanisms of cardiac complications in patients with COVID-19 are reviewed. Before an effective vaccine or medicine is available, supportive therapy and identifying patients who are at high risk of cardiac complications are important.

Keywords: cardiac complications; cardiac injury; coronavirus disease-2019; inflammatory factors; pneumonia.

Publication types

  • Review

MeSH terms

  • COVID-19*
  • Cardiovascular Diseases* / diagnosis
  • Cardiovascular Diseases* / epidemiology
  • Cardiovascular Diseases* / etiology
  • Coronavirus Infections* / diagnosis
  • Coronavirus Infections* / epidemiology
  • Coronavirus Infections* / therapy
  • Coronavirus*
  • Humans
  • Pandemics
  • SARS-CoV-2